Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato‐O, O′)‐diammine Platinum (II) (NSC 375101D)
Authors:
Open Access
- 1 February 1990
- journal article
- research article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 81 (2) , 196-200
Abstract
Thrombocytopenia is the most serious dose‐limiting toxicity of (glycolato‐O, O′)‐diammine platinum (II) (254‐S; NSC 375101D), one of the new platinum analogues. A total of 38 patients treated with 100 mg of 254‐S per m2 in a clinical phase II study were retrospectively analyzed to determine the factors influencing thrombocytopenia. Performance status, sex, age and prior chemotherapy did not affect either the percent reduction of platelets or the nadir platelet count. However, creatinine clearance (Ccr.: ml/min) was found to be a predictive variable for thrombocytopenia. There was a significant relationship between nadir platelet count and Ccr. (R2=0.637) or relative dose [RD = (dose of 254‐S: mg/m2)/Ccr.] (R2= 0.707). From these observations, the following equations for predicting nadir platelet count associated with administration of 254‐S were proposed. ((A)) ((B)) If we administer 100 mg of 254‐S per m2 to a patient with Ccr. of less than 40.3 ml/min, thrombocytopenia of grade 3 or more according to the Eastern Cooperative Oncology Group (ECOG) criteria (< 50,000/mm3) can be predicted from equation (A). In these patients, dose modification using equation (B) is recommended.Keywords
This publication has 9 references indexed in Scilit:
- A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusionCancer Chemotherapy and Pharmacology, 1989
- A LIMITED SAMPLING STRATEGY FOR CYCLOPHOSPHAMIDE PHARMACOKINETICS1989
- Pharmacokinetics of (glycolato-0,0?)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatinCancer Chemotherapy and Pharmacology, 1989
- PHASE-I STUDY AND PHARMACOKINETICS OF MENOGARIL (NSC 269148) IN PATIENTS WITH HEPATIC-DYSFUNCTION1987
- PREDICTION OF HEMATOLOGIC TOXICITY OF CARBOPLATIN BY CREATININE CLEARANCE RATE1987
- A case report of pulmonary adenocarcinoma responding to (glycolato-0,0') diammineplatinum (II), a new platinum complex.1987
- HUMAN PHARMACOKINETICS, EXCRETION, AND METABOLISM OF THE ANTHRACYCLINE ANTIBIOTIC MENOGARIL (7-OMEN, NSC 269148) AND THEIR CORRELATION WITH CLINICAL TOXICITIES1986
- PROSPECTIVE VALIDATION OF A PHARMACOLOGICALLY BASED DOSING SCHEME FOR THE CIS-DIAMMINEDICHLOROPLATINUM(II) ANALOG DIAMMINECYCLOBUTANEDICARBOXYLATOPLATINUM1985
- PHARMACOKINETICS AND DOSAGE REDUCTION OF CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM IN PATIENTS WITH IMPAIRED RENAL-FUNCTION1984